发明人杨光,唐晓军,钱学锋. "一种博舒替尼杂质31的合成方法" [P]. 中国发明专利, 专利号 CN 108852609 A, 授权公告日 2017-10-04.
Brown S R, Hughes D C, Anderson J P. "Method for the Synthesis of Bosutinib Impurity 31" [P]. US Patent, US 10770596 B2, 2018-04-07.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 博舒替尼杂质31 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2021, 437, 5816-5838.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 博舒替尼杂质31 as an Impurity". Anal. Methods, 2019, 2234, (10), 1315-1338.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Bosutinib Impurity 31 Using HRMS and NMR". Environ. Sci. Technol., 2018, 1434, (3), 244-254.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 博舒替尼杂质31 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2012, 1596, (4), 741-754.